Cost Effectiveness in RCC – What is Value and Who gets to decide?

Robert G. Uzzo, MD of Fox Chase Cancer Center presents his thoughts on the Cost Effectiveness in Renal Cell Carcinoma – What is Value and Who gets to decide? at the 2017 Annual Kidney Cancer Association in Miami, FL